Q&A Document on QP Declaration updated
Recommendation
10/11 September 2025
Understand the Implications of becoming a QP
Register now for ECA's GMP Newsletter
The joint Q&A of CMDh and CMDv on the QP Declaration has been updated and was now published a revision 8 (CMDh/340/2015/Rev.8).
The answer (Verterinary) to question 7 was updated, with the subtraction of the final paragraph:
"In addition, it should be noted that in accordance with the requirements of VRA E.II.1 and CMDv's published Q&As on variations (specifically 2.11 and 2.12), it is also possible, as a means of "otherwise transmitted", to include any new QP declaration(s), which reflect the positive outcomes of any new site audits as part of any one of these chapter F variations and this approach is encouraged. In these cases, no separate variation application for the change in the audit date has to be submitted. However, the change has to be clearly mentioned in the scope of the application form as well as under "present/proposed". [deleted]
Other updates and additions from the previous version are highlighted in red throughout this document.
Related GMP News
25.06.2025Is Knowledge Management a Part of the Pharmaceutical Quality System?
11.06.2025Swissmedic differentiates GMP Scope for Manufacturing and Preparation for Administration
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review